about
Transport of fluorescent chenodeoxycholic acid via the human organic anion transporters OATP1B1 and OATP1B3.Preparation of neocarzinostatin apoprotein mutants and the randomized library on the chromophore-binding cavity.Severe toxicity induced by accumulation of active sunitinib metabolite in a Japanese patient with renal cell carcinoma: a case report.Mitochonic Acid 5 (MA-5) Facilitates ATP Synthase Oligomerization and Cell Survival in Various Mitochondrial Diseases.Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MS.Mitochonic Acid 5 (MA-5), a Derivative of the Plant Hormone Indole-3-Acetic Acid, Improves Survival of Fibroblasts from Patients with Mitochondrial Diseases.A simultaneous determination method for 5-fluorouracil and its metabolites in human plasma with linear range adjusted by in-source collision-induced dissociation using hydrophilic interaction liquid chromatography-electrospray ionization-tandem massPreference of Conjugated Bile Acids over Unconjugated Bile Acids as Substrates for OATP1B1 and OATP1B3.Mitochonic Acid 5 Binds Mitochondria and Ameliorates Renal Tubular and Cardiac Myocyte Damage.Contribution of the drug transporter ABCG2 (breast cancer resistance protein) to resistance against anticancer nucleosides.Successful Colistin Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection Using a Rapid Method for Determination of Colistin in Plasma: Usefulness of Therapeutic Drug Monitoring.Identification of Two Sulfated Cholesterol Metabolites Found in the Urine of a Patient with Niemann-Pick Disease Type C as Novel Candidate Diagnostic Markers.Production of 18O-single labeled peptide fragments during trypsin digestion of proteins for quantitative proteomics using nanoLC-ESI-MS/MS.Analysis of phosphorylated peptides by double pseudoneutral loss extraction coupled with derivatization using N-(4-bromobenzoyl)aminoethanethiol.Effect of cisplatin-induced acute renal failure on bioavailability and intestinal secretion of quinolone antibacterial drugs in rats.Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3β-hydroxysteroid dehydrogenase deficiencSimple quantification of lansoprazole and rabeprazole concentrations in human serum by liquid chromatography/tandem mass spectrometry.Rapid screening of antineoplastic candidates for the human organic anion transporter OATP1B3 substrates using fluorescent probes.Determination of chlorhexidine (CHD) and nonylphenolethoxylates (NPEOn) using LC-ESI-MS method and application to hemolyzed blood.Functional characterization of 21 allelic variants of dihydropyrimidinase.Simultaneous analysis of oral anticancer drugs for renal cell carcinoma in human plasma using liquid chromatography/electrospray ionization tandem mass spectrometry.Simultaneous quantitation of sphingoid bases and their phosphates in biological samples by liquid chromatography/electrospray ionization tandem mass spectrometry.Development of a Liquid Chromatography-Tandem Mass Spectrometric Method for Quantification of Mycophenolic Acid and Its Glucuronides in Dried Blood Spot Samples.Functional characterization of 9 CYP2A13 allelic variants by assessment of nicotine C-oxidation and coumarin 7-hydroxylation.Impact of clinical factors and UGT1A9 and CYP2B6 genotype on inter-individual differences in propofol pharmacokinetics.Potential Drug Interactions Mediated by Renal Organic Anion Transporter OATP4C1.Interactions of crizotinib and gefitinib with organic anion-transporting polypeptides (OATP)1B1, OATP1B3 and OATP2B1: gefitinib shows contradictory interaction with OATP1B3.Functional Characterization of 34 CYP2A6 Allelic Variants by Assessment of Nicotine C-Oxidation and Coumarin 7-Hydroxylation Activities.[A Case of Renal Cell Carcinoma with High Everolimus Blood Concentrations and Hyperglycemia Due to Everolimus-Induced Hepatic Dysfunction].Long-term relationship between everolimus blood concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma: a prospective studyMicrodetermination of the 6,15-diketo-13,14-dihydroprostaglandin F1alpha in human plasma using gas chromatography/selected ion monitoring with [18O]6,15-diketo-13,14-dihydro-prostaglandin F1alpha as an internal standardcGMP transport by vesicles from human and mouse erythrocytesSimultaneous quantification of seven prostanoids using liquid chromatography/tandem mass spectrometry: the effects of arachidonic acid on prostanoid production in mouse bone marrow-derived mast cellsScreening of antibiotics that interact with organic anion-transporting polypeptides 1B1 and 1B3 using fluorescent probesA rapid and sensitive LC/ESI-MS/MS method for quantitative analysis of docetaxel in human plasma and its application to a pharmacokinetic studyIdentification and elimination of ion suppression in the quantitative analysis of sirolimus in human blood by LC/ESI-MS/MSA full validated hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the quantification of oxaliplatin in human plasma ultrafiltratesA novel extraction method based on a reversible chemical conversion for the LC/MS/MS analysis of the stable organic germanium compound Ge-132Erratum to: Determination of ω-6 and ω-3 PUFA metabolites in human urine samples using UPLC/MS/MSShifting the Linear Range in Electrospray Ionization by In-Source Collision-Induced Dissociation
P50
Q33236324-FAABE19C-503F-4D68-B66E-E8251D64F52FQ33241688-1661885C-51CA-41CD-A857-CD009C3EDC6BQ33438859-6C0D70E8-A170-4189-B732-315DADDD0016Q33817804-1077F67B-9873-47D7-9680-2DA082BA4D91Q34457553-730D1444-8BA0-4384-94BF-56658F8C1C16Q35676490-306B61AC-32BD-405A-B644-CF132393A803Q35989925-48F4208B-0F2A-4C07-AD96-26E22F6B4FE8Q36242746-0CDDF650-0C68-41BD-BF38-1580A7F0ECFBQ37052056-2BD814C9-8D1D-4427-A8BA-1CD55A8D3EBCQ39944267-9B3E9441-FDD9-4412-922D-26E7197086D0Q41117701-A19088C0-B7E1-4A13-B755-DFCEA2E112CAQ41843571-33B13311-D254-416F-992F-21A9F326371AQ43055718-8BDD5772-4654-4CB3-A5E6-18CAED88539CQ43257658-81B86FE3-FE6F-46A1-A861-3C06E81FF633Q44806134-DFB1EA45-A918-45FD-8E90-4E1BDAD5ECD8Q46143638-13C11EA2-C402-4CFC-9209-9AC7545707E2Q46538680-9B154807-B87E-426A-B03B-AC63FEE5BC90Q46848168-9DB734F6-29AB-4CD1-BDA3-ABCD4A162F66Q46869982-EE6EAAE9-F59E-496C-812C-FCD3279EA030Q47824644-6C2FC457-DF2D-498A-90DF-07468FC6A5CDQ48337393-B142E63C-4FAA-46B7-9DB1-4D293A72DDC1Q48546023-67E293A2-E9A3-43A5-BC5D-6957BC87C0B7Q48555991-5062C926-F54D-4D97-82F9-3C4305F897A8Q49999924-A554FC92-AA1C-4477-A712-F38B492275E5Q50146114-589BBF46-E0B7-4FD8-8746-44342B5688A8Q50861472-6BCF5E97-2DBB-49FE-8942-77F9063B789BQ51069180-65FE02D4-8AEB-4BA1-98B0-230508A6193BQ51265079-F137AD0A-B006-4DFE-9B8C-70B05560A844Q52911597-397E322B-B9F3-4F24-AFA6-91D95D36E5A1Q64103860-C5EAA53E-9F19-4A80-8536-C4DFC1728425Q73179632-030DC4EC-5B61-4544-9CA7-B79A3F870E8FQ79576500-57889A9B-6EBD-4FC9-9384-4C64063913D9Q80523590-656476D9-FD64-4FCB-BD31-21D049EBEF52Q83524954-78AE8E0E-E083-427E-8F87-A38234B8DEFAQ83691680-706285C5-6640-44FC-8442-9A6952BB0F43Q83705826-C7E30437-26BD-43C9-B8BF-566E5B4E594CQ84941212-571434D2-48E8-46F1-BF3F-77AE91B48DE3Q86600323-C12D621A-EB6B-445A-B660-8481ECAC9FAFQ86815524-EE17F098-FB95-4CAE-922A-535D83394BD6Q89109896-3AFCB2BE-D75D-4DA0-928D-B83920A6B374
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Hiroaki Yamaguchi
@ast
Hiroaki Yamaguchi
@en
Hiroaki Yamaguchi
@es
Hiroaki Yamaguchi
@nl
Hiroaki Yamaguchi
@sl
type
label
Hiroaki Yamaguchi
@ast
Hiroaki Yamaguchi
@en
Hiroaki Yamaguchi
@es
Hiroaki Yamaguchi
@nl
Hiroaki Yamaguchi
@sl
prefLabel
Hiroaki Yamaguchi
@ast
Hiroaki Yamaguchi
@en
Hiroaki Yamaguchi
@es
Hiroaki Yamaguchi
@nl
Hiroaki Yamaguchi
@sl
P106
P31
P496
0000-0003-3021-6120